# ROCKET PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:1983b7ba-a9df-445e-933b-d06c7b8194a3 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/rocket-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 10 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:44:42.024694+00:00 | | Last reviewed | 2026-10-19T14:44:42.024694+00:00 | ## Identity - Legal name: ROCKET PHARMACEUTICALS, INC. - Display name: ROCKET PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T17:42:20.289655+00:00 | | Completeness | 0.409 | | Record Quality | 0.846 | | Directors | 8 | | Committees | 3 | | Governance events | 15 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - David P. Southwell: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:5 - Elisabeth Björk: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-06. Committees: AUDIT COMMITTEE (member). claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:6 - Fady Malik: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:7 - Gaurav Shah: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:8 - Mikael Dolsten: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:9 - Peter Fong: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. Committees: compensation committee (member); nominating and corporate governance committee (member). claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:10 - Piratip Pratumsuwan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-06. Committees: AUDIT COMMITTEE (member). claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:11 - Roderick Wong: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:12 ## Committees - AUDIT COMMITTEE (audit). Chair: NOT_PUBLISHED. Members: Elisabeth Björk (member, current); Piratip Pratumsuwan (member, current). committee_id=alpha:committee:rocket-pharmaceuticals-inc:audit-committee - compensation committee (compensation). Chair: NOT_PUBLISHED. Members: Peter Fong (member, current). committee_id=alpha:committee:rocket-pharmaceuticals-inc:compensation-committee - nominating and corporate governance committee (nominating_governance). Chair: NOT_PUBLISHED. Members: Peter Fong (member, current). committee_id=alpha:committee:rocket-pharmaceuticals-inc:nominating-and-corporate-governance-committee ## Executive leadership - Christopher Stevens: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:13 - Giovanni Caforio, M.D.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:14 - John Militello, CPA: Vice President of Finance, Senior Controller Treasurer, Principal Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:15 - Jonathan Schwartz, M.D.: Chief Science Gene Therapy Officer. Status: current. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:16 - Martin Wilson, J.D.: General Counsel and Chief Corporate Officer, Senior Vice President, Interim Principal Financial Officer [GC]. Status: current. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:17 - Sarbani Chaudhuri, M.B.A.: Chief Commercial Medical Affairs Officer. Status: current. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:18 - Syed Rizvi, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:19 ## Governance events - DIRECTOR_APPOINTED: Elisabeth Björk seat on ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:r36ohx1b2mlvv - DIRECTOR_APPOINTED: Piratip Pratumsuwan seat on ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:1559zf3co0d9 - EXECUTIVE_APPOINTED: Christopher Stevens executive of ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:mnyjhl1wzrp87 - CEO_CHANGED: Giovanni Caforio, M.D. executive of ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:1mu5vm51ycsxst - EXECUTIVE_APPOINTED: John Militello, CPA executive of ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:2mqbs21u3acre - EXECUTIVE_APPOINTED: Jonathan Schwartz, M.D. executive of ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:a2dxcjkaeaj - GC_CHANGED: Martin Wilson, J.D. executive of ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:1ru5fl01l51i9y - EXECUTIVE_APPOINTED: Sarbani Chaudhuri, M.B.A. executive of ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:wilazhz5fhs7 - EXECUTIVE_APPOINTED: Syed Rizvi, M.D. executive of ROCKET PHARMACEUTICALS, INC., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:s4lzk01shv6pm - DIRECTOR_APPOINTED: Peter Fong seat on ROCKET PHARMACEUTICALS, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:5c4bh34cwpkl - DIRECTOR_APPOINTED: Mikael Dolsten seat on ROCKET PHARMACEUTICALS, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:b20zoor6pnnc - DIRECTOR_APPOINTED: Fady Malik seat on ROCKET PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:7d2m68nkd8a8 - DIRECTOR_APPOINTED: Gaurav Shah seat on ROCKET PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:pdxydoe2jdei - DIRECTOR_APPOINTED: Roderick Wong seat on ROCKET PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:1ak3yrjilut55 - DIRECTOR_APPOINTED: David P. Southwell seat on ROCKET PHARMACEUTICALS, INC., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-19T14:44:42.024694+00:00. event_id=alpha:event:transition:1w830yn1n0947z ## Scoped resources - `alpha://company/rocket-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record - `alpha://company/rocket-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/rocket-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/rocket-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=board - `alpha://company/rocket-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/rocket-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/rocket-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/rocket-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/rocket-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/rocket-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/rocket-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/rocket-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/rocket-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/rocket-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/rocket-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/rocket-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/rocket-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/rocket-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/rocket-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/rocket-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=events - `alpha://company/rocket-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/rocket-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/rocket-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:21: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"member","person":{"alpha_id":"alpha:person:elisabeth-bj-rk-rcktw","name":"Elisabeth Björk"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:22: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"member","person":{"alpha_id":"alpha:person:piratip-pratumsuwan-rcktw","name":"Piratip Pratumsuwan"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:24: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:peter-fong-rcktw","name":"Peter Fong"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:26: `{"kind":"committee_appointment","original_name":"nominating and corporate governance committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:peter-fong-rcktw","name":"Peter Fong"},"source_id":"governance_people_committees"}` ## Leadership - David P. Southwell: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:5. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Elisabeth Björk: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:6. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Fady Malik: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Gaurav Shah: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Mikael Dolsten: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:9. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Peter Fong: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Piratip Pratumsuwan: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:11. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Roderick Wong: Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:12. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020. - Christopher Stevens: Chief Operating Officer. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:13. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e974ec27e3eb1df3f06d75b3c110b75e0723840c681afa11c6ca0b3865aecd4c. - Giovanni Caforio, M.D.: Chief Executive Officer and Director. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:14. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2b9bf80b2ca4c52de6bd868b0852b33dd13c77389889a536bd47b96958486e6. - John Militello, CPA: Vice President of Finance, Senior Controller Treasurer, Principal Accounting Officer. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:15. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c8eb669fbc19802c2da6066a9546d2115d2d221592d8c6e588dec9f50b8654a. - Jonathan Schwartz, M.D.: Chief Science Gene Therapy Officer. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:16. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb1235d4ca04c5b9558090a25a0d9434749c6531bf61c9e4407b2b268d21340b. - Martin Wilson, J.D.: General Counsel and Chief Corporate Officer, Senior Vice President, Interim Principal Financial Officer. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:17. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2d61a233a32edd4c18b73903a41033501015a75ab25e9d9b0effc4bf07a58c74. - Sarbani Chaudhuri, M.B.A.: Chief Commercial Medical Affairs Officer. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:18. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:368b09fc195c5ac6db90f75c74618b9e0b539ae6a4f6504ee502ec320e1429a1. - Syed Rizvi, M.D.: Chief Medical Officer. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:leadership_role:19. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:766254833650452f3e993e7e5936b31c6afa03af0003b5edc9f77022d3891e16. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - AUDIT COMMITTEE: Chair not stated; Members Elisabeth Björk; Piratip Pratumsuwan. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c. - compensation committee: Chair not stated; Members Peter Fong. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c. - nominating and corporate governance committee: Chair not stated; Members Peter Fong. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ROCKET PHARMACEUTICALS, INC.. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fa68edd1900ee2159ead840015601ca5df706690e35df4c6f1939b5d55966440. ## Entity Status - Public listing published. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fa68edd1900ee2159ead840015601ca5df706690e35df4c6f1939b5d55966440. ## Published Fact - US. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fa68edd1900ee2159ead840015601ca5df706690e35df4c6f1939b5d55966440. ## Committee Appointment - Elisabeth Björk: member, AUDIT COMMITTEE. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c. - Piratip Pratumsuwan: member, AUDIT COMMITTEE. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c. - Peter Fong: member, compensation committee. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c. - Peter Fong: member, nominating and corporate governance committee. Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c. ## Security Listing - RCKT (NASDAQ). Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fa68edd1900ee2159ead840015601ca5df706690e35df4c6f1939b5d55966440. - RCKTW (NASDAQ). Claim: alpha:claim:company:1983b7ba-a9df-445e-933b-d06c7b8194a3:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fa68edd1900ee2159ead840015601ca5df706690e35df4c6f1939b5d55966440. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:fa68edd1900ee2159ead840015601ca5df706690e35df4c6f1939b5d55966440: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc). - alpha:projection-evidence:document:46a20bdaea3ae89bc2f71afd36b593ceba13d060e6a407b2ef1ae283c83ee020: [DEF 14A ny20067122x2_def14a.htm](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:document:e974ec27e3eb1df3f06d75b3c110b75e0723840c681afa11c6ca0b3865aecd4c: [RCKT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:document:e2b9bf80b2ca4c52de6bd868b0852b33dd13c77389889a536bd47b96958486e6: [RCKT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:document:4c8eb669fbc19802c2da6066a9546d2115d2d221592d8c6e588dec9f50b8654a: [RCKT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:document:cb1235d4ca04c5b9558090a25a0d9434749c6531bf61c9e4407b2b268d21340b: [RCKT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:document:2d61a233a32edd4c18b73903a41033501015a75ab25e9d9b0effc4bf07a58c74: [RCKT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:document:368b09fc195c5ac6db90f75c74618b9e0b539ae6a4f6504ee502ec320e1429a1: [RCKT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:document:766254833650452f3e993e7e5936b31c6afa03af0003b5edc9f77022d3891e16: [RCKT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). - alpha:projection-evidence:9f39f3a0cf7697fc8fcfe480e59be360241a232a0408919fcf48d1e0efb59c1c: [AUDIT COMMITTEE](https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/rocket-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/rocket-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/rocket-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/rocket-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T17:42:19.967615+00:00; recorded 2026-10-19T17:42:19.967615+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.